Highlights – 1st Quarter 2013
- Sales rise by 3.8% to € 2,660 million; solid organic growth of 5.0% stands against a foreign exchange impact of –1.4%
- Organic sales growth fueled by all four divisions
- EBITDA pre one-time items up 18.8% to € 801 million thanks to good business performance and progress with the “Fit for 2018” efficiency program as planned
- Net income soars by 54.1% to € 266 million, earnings per share before one-time items up 27.1% to € 2.11
- Free cash flow increases by 4.5% to € 439 million despite cash outflow of around € 100 million for efficiency measures and a € 195 million increase in working capital
- Guidance for FY 2013: EBITDA pre ~ € 3.1 to 3.2 billion
| XLS |
|
Merck Group | Key figures – Q1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million |
Q1 – 2013 |
Q1 – 2012 |
Change |
|
Total revenues |
2,760.5 |
2,644.9 |
4.4% |
|
Sales |
2,660.4 |
2,563.9 |
3.8% |
|
Operating result (EBIT) |
399.4 |
310.6 |
28.6% |
|
Margin (% of sales) |
15.0% |
12.1% |
|
|
EBITDA |
753.8 |
653.3 |
15.4% |
|
Margin (% of sales) |
28.3% |
25.5% |
|
|
EBITDA pre one-time items |
801.1 |
674.3 |
18.8% |
|
Margin (% of sales) |
30.1% |
26.3% |
|
|
EPS pre one-time items (€) |
2.11 |
1.66 |
27.1% |
|
Free cash flow |
438.6 |
419.8 |
4.5% |